Direct Raman imaging techniques are demonstrated to study the drug distribution in living cells. The advantage of Raman imaging is that no external markers are required, which simplify the sample preparation and minimally disturbs the drug mechanism during imaging. The major challenge in Raman imaging is the very weak Raman signal.
INTRODUCTION
The recent implementation of rational drug design, combinatorial chemistry techniques, and high throughput screening have led to large numbers of new drug leads.
There is a tremendous need for cost-effective and efficient approaches to evaluate the efficacy of these potential drugs. Early assessment of drug efficacy is critical for pharmaceutical companies because it will save millions of dollars that would otherwise be spent on animal and clinical studies on less efficient drug leads.
A cost-effective way of evaluating drug efficacy at the early stage of drug development is to understand its action at the cellular level 1, 2 . For example, the cellular uptake, intracellular distribution, binding characteristics, intracellular pharmacokinetics, and cellular resistance of a drug generally determine the efficacy of the drug.
Laser scanning fluorescence microscopy has been used for the in vitro study of drug action at the cellular level for many years [3] [4] [5] [6] [7] [8] [9] [10] . However, the auto-fluorescence of most drugs is weak and unspecific (broad bandwidth), therefore, molecular-specific images often cannot be acquired by imaging of auto-fluorescence. Instead, certain fluorophores need to be used as a fluorescing label to selectively bind to specific regions of the drug molecules by chemical or physical means before imaging 11, 12 . The need to prepare and, subsequently, test external markers or labels often complicates the assessment of drug action. In addition, using a relatively large fluorophore molecule as a tag on to a (often smaller) drug molecule can potentially change the activities of the drug in tumor cells. The fluorescent markers used in the specimen may cause undesirable pharmacological or toxicological effects. Also, a suitable marker is often not available 2 for all bio-molecules. The continuous loss of fluorescence intensity during measurement due to photon bleaching, and the potential for photo-damage to the bio-specimen due to the use of ultraviolet wavelengths, are also fundamental problems of fluorescence microscopy.
The Raman spectrum of a particular substance depends on the structure (vibrational states of chemical bonds) of the molecules, and therefore it can identify a particular type of molecule by its unique combination of scattered frequencies (also referred to as Raman peaks or Raman modes). Raman imaging can provide an overview of the spatial arrangement of a particular type of molecule within a heterogeneous specimen. Raman imaging requires no external markers, dyes, or labels as required in fluorescent imaging. In addition, the near-infrared excitation used in Raman imaging of the present work has a number of advantages for biological systems, such as producing less laser-induced fluorescence and photo-thermal degradation, and allowing better perspective depth (>1 mm) into a sample 13, 14 .
The major challenge in Raman applications is the inherently weak signals in
Raman scattering comparing to the signals in Rayleigh scattering or fluorescence. Raman imaging, especially direct Raman imaging, was not practical until the recent development of robust laser sources and low-noise CCD (charge-coupled device) detectors 15, 16 . For many years Raman images have been acquired by pixel-to-pixel (or line-to-line) laserscanning methods [17] [18] [19] [20] [21] [22] . Because the Raman signal is weak and takes a relatively long time to obtain the spectrum for each pixel, the scanning time for a whole image is considerable. For example, complete scanning of a 128x128-pixel Raman image using point illumination may take overnight, which is not a suitable scanning rate for living cell studies.
With the inventions of dielectric filters 23 , acousto-optic tunable filters (AOTF) 24 , and liquid crystal tunable filters (LCTF) [25] [26] [27] , direct (or wide field) Raman imaging became an alternative imaging method. Direct Raman images are acquired at a selected
Raman mode from a sample that is globally illuminated by an expanded laser beam ( Figure 1 ). The imaging time is equivalent to the scanning time for one pixel in the laserscanning method. In addition, the fidelity of the direct Raman images is primarily limited by the objective lens used in the microscope. Therefore, direct Raman imaging has the potential to provide an efficient way of obtaining high-definition Raman images. Direct
Raman imaging has been used to study the distribution of the non-fluorescent photodynamic therapy agent cobalt-octacarboxy phthalocyanine [CoOCP] inside the K562 leukemia cells [28] [29] [30] . These studies suggest the potential application of Raman imaging in drug research. However, in order to extract correct and useful information from Raman images with weak signals, a systematic procedure is required.
In this paper, a model was first developed for direct Raman microscopic images to describe the degradation of Raman signals by several processes: non-uniform illumination of the laser excitation source, distortion by the microscope system, and the influence of additive signal-dependent Gaussian noise. Using this model, imageprocessing algorithms were demonstrated to restore a recorded Raman image into a considerably improved image that better reflects the molecular distributions. 4 The general Raman imaging and data analysis techniques were then applied to the visualization of an anticancer drug -paclitaxel within living tumor cells. Paclitaxel is an important antimitotic agent for which the mechanisms of interaction with a cell are wellestablished [31] [32] [33] [34] and is a suitable candidate for validation of Raman imaging capabilities.
MODELING AND PROCESSING OF DIRECT RAMAN IMAGES
Assume a laser beam illuminates at a focal plane (z) inside a three-dimensional specimen. The Raman scattering coefficient for the heterogeneous area is K(x,y,z), which is proportional to the concentration of specific chemical bonds to be imaged. The fluorescence signal from the heterogeneous specimen is K 0 (x,y,z). Then the scattering signal s(x,y,z) can be modeled as:
where t is the exposure time. Usually the intensity of the illumination at the focal plane is not uniform but dependent on the locations (x,y) due to the imperfections in the laser expanding system. This lack of homogeneity of the illumination, indicated by i(x,y), causes a non-uniform illumination effect in the recorded images.
A direct Raman image is a wide-field image that is taken at a specific focal plane within a sample. However, this image is the sum of in-focus information from the focal plane and out-of-focus information from the neighborhood planes due to the finite recording aperture and the limited depth of focus of the imaging system 35, 36 . In other words, the Raman signal s(x,y,z) is blurred by the microscopic system. This blur is characterized in terms of the microscope's point spread function (PSF) h(x,y,z) or its (1) assumed to be linear and time-invariant, then the recorded image g(x,y,z) can be represented as:
where * is the linear convolution operator. The blurred Raman signal was further degraded by the additive noise n(x,y,z) that occurs during image recording.
The purpose of the Raman image processing is to determine the Raman scattering 
Noise Reduction Using Anisotropic Median-Diffusion Filter
A Raman image is a molecular image, which displays the distribution of molecules. Such an image can be modeled as a piecewise-smooth image, which can be divided into several regions. Each region is chosen such that the changes in molecular concentration within the region are small and gradual. The intensities between the different regions are quite dissimilar because of the significant difference in molecular concentration. For these kind of piecewise-smooth images, the anisotropic mediandiffusion filter was found 37 to be a suitable denoising filter. The anisotropic mediandiffusion filter is described as: 
where K is the threshold of the local gradients, which is tuned for a particular application.
The Window in Eq. 3 is the window for the median operator. A 3x3 window is usually used.
The anisotropic median-diffusion filter is especially useful to smooth images with low signal-to-noise ratio, such as the Raman images. It can effectively reduce the Gaussian noise without blurring the edges on the images. A quantitative study has shown (5) (4) that the anisotropic median-diffusion smoothed images are very close to the original images in correlation, mean luminance and contrast 37 .
Correction of Non-uniform Illumination
After reducing the noise, the non-uniform illumination i(x,y) needs to be corrected (see Equation 2) . A flat field image is used as a reference image to correct the lateral nonuniform illumination. The effect of illumination difference in the axial direction is considered in PSF.
According to the image model, a recorded flat-field reference image (after smoothing) can be expressed as:
where K flat is a constant here. The residue noise after smoothing is ignored in Eq. 6 for simplicity. The OTF of a microscope system is usually a low-pass filter (for example, the microscope system used in this research has a lateral cut-off frequency of 0.57 µm -1 and an axial cut-off frequency of 0.15 µm -1 ). Therefore, Eq. 6 can be simplified to:
because of the "zero" frequency characteristics of the K flat . The reference image is then normalized by its own median value to give the compensating image c(x,y):
Dividing c(x,y) by the denoised Raman image g s (x,y,z) we get the compensated image:
The above compensation algorithm keeps the median intensity of the image unchanged. This algorithm is based on the assumptions that the Raman scattering coefficient is linearly related to the exposure time. It is also important to smooth the image before the compensation. Otherwise, the noise may be amplified after the compensation algorithm.
Three-dimensional Image Deconvolution
The objective of three-dimensional deconvolution is to restore the blurred image by using the PSF of the imaging system. After the deconvolution, it will reduce the infocus-plane blurs caused by the limited aperture of the system as well as the out-of-focusplane blurs resulted from the limited depth-of-field of the system. Many three-dimensional deconvolution algorithms have been developed, including the inverse filter, the Wiener filter, the Nearest-Neighbor deconvolution, the constrained iterative method, and the expectation-maximization maximum-likelihood (EM-ML) deconvolution. When restoring an image with all the information at the neighborhood planes available and no noise present, the deconvolution results from all these algorithms are very similar. However, in practice, some amount of noise always exists in a recorded image, even after smoothing by the anisotropic median-diffusion filter. In addition, there are often only a few images that can be recorded at different defocus planes within a limited period of time. Especially in the case of Raman imaging of living cells, we were only able to get one image (at a specific focal plane) to represent the drug distributions using the current instrumentation. This is again due to the relatively long exposure time required for Raman imaging. be performed after replicating the recorded image as the neighborhood images. This simplification is based on the assumption that there is no abrupt change among the neighborhood images. However, if the assumption is not true, the three-dimensional deconvolution will not effectively remove the blurred information from the neighborhood planes.
Different deconvolution algorithms were compared on a three-dimensional cell model under the no-neighborhood condition 39 . The EM-ML deconvolution was found to achieve better results when compared with the other algorithms. The EM-ML deconvolution was derived from the Bayesian theory with Poisson noise model. An iterative algorithm of the deconvolution, developed by Richardson and Lucy 40, 41 , is described as follows: is the restored images at nth iteration, and h(x,y,z) is the PSF of the imaging system. The non-negative constraint is applied to the restored images after each iteration.
Under the no-neighborhood condition in this study, the g c (x,y,z) is composed of a image recorded at the focal plane plus the neighborhood images created by replicating the focal plane image. All these images go through the denoising and non-uniform illumination correction procedures as described above. (10) prior to performing the deconvolution. Studies 42, 43 have shown that the background intensity has critical influence on the performance of the EM-ML deconvolution. This is because the existence of the background makes the nonnegative constraint less effective.
In this study, the image background could be the fluorescence from the aqueous solution, which can be assumed uniform across the image. This background was subtracted from g c (x,y,z) before deconvolution.
Elimination of Fluorescence Signal
After deconvolution, Equation 2 became:
The next processing step is to subtract the fluorescent signal K 0 (x,y,z). The fluorescence signal is different from the fluorescence background discussed above. It is generated by the specimen, so it is usually non-uniform due to the heterogeneity of the specimen. The However, when the laser is used for direct imaging, the beam must be expanded and spread over thousands of pixels. In such applications, it provides inadequate illumination power. In addition, the diode laser source has a line-shape beam so that the imaging area suffers severe non-uniform illumination. The Ti:Sapphire laser, pumped by a 7W argonion laser (Lexel 95-7), emits near-infrared wavelength with the maximum power of 1 W.
The Ti:Sapphire laser also has a Gaussian beam shape which greatly improves the beam quality after beam expansion. In this study the laser was tuned to 782 nm to match the holographic notch filter in the Raman system.
The Raman system can achieve spectral resolution of 1 cm -1 for spectrum measurement with a grating system. For direct imaging, the dielectric filter has a bandwidth of 10-20 cm -1 . The Raman system is placed in a dark room and is stabilized on an anti-vibration In this study, the excitation wavelength is λ = 782, the maximum resolution that can be achieved is about 0.53 µm. The resolution of the system is also affected by the magnification of the microscope, the pixel size of the CCD camera, and the sampling rate. The complete optical characteristics of the Raman system is determined by its PSF (or OTF), which was estimated in this study by using small polystyrene microspheres (0.2 µm in diameter) as the point light source 39 . This PSF will be used in threedimensional deconvolution.
The Raman Band for Imaging the Drug
Paclitaxel is an anticancer drug often used to treat breast cancer, ovarian cancer, and non-small cell lung cancer. Paclitaxel was selected for this study because its interactions with cellular molecules have been well studied. This knowledge will help us examine the results and determine the capability of the Raman imaging technology. 
Raman peak at 1002 cm -1 is due to the sp 3 hybridized carbon-carbon (C-C) vibration. The
Raman peak at 1601 cm -1 is due to the carbon-carbon double bond (C=C) stretching vibration.
The powder paclitaxel, however, is not soluble in water, thus it cannot be used to In order to detect paclitaxel in a cell, Raman and fluorescent signals from a cell also need to be studied. In this study, the human breast tumor cell line, MDA-435, was used. Figure 5 shows the Raman spectrum (with no fluorescence baseline correction) of the cytoplasm (at one local spot) of an MDA-435 breast tumor cell. The Raman spectrum of the cell nucleus (not shown here) is very similar to the spectrum of the cytoplasm. The carbon-carbon stretching mode (at the Raman peak about 1003 cm -1 ) from the molecules (proteins) inside cell is also presented on the cell spectrum. This peak is very close to the 14 -1 Raman band that we will use for detecting the paclitaxel. Fortunately, the Raman signal at this peak from the cell is relatively weaker than that from the paclitaxel, thus the intrinsic Raman signal from the cell should have a small contribution to the Raman image at 1000 cm -1 . To further distinguish the changes of Raman signals before and after drug treatment, the Raman images before the cell exposure to the paclitaxel solution will be used as the control case to be compared with the Raman images after the drug treatment. In summary, one Raman image will be taken at 1000 cm -1 to detect the paclitaxel. Another Raman image will be taken at 1080 cm -1 to correct the contribution of fluorescent signal on the 1000 cm -1 image.
Cell Preparation and Imaging Procedure
Approximately 10 After taking images in a control situation, PBS was then replaced by the 0.3 mg/ml (or 350 µM) paclitaxel solution to start the drug treatment. The cells were exposed to paclitaxel for one hour. During the one-hour drug treatment, the same images were recorded to show the cellular distributions of paclitaxel during the drug treatment. After one hour of treatment, the paclitaxel solution was washed out using PBS, and the cells were returned to the PBS medium. Images were then acquired to show the drug retained by the cell.
Data Processing and Analysis
As described above, each image record contains a white light image and two
Raman images at 1000 cm -1 and 1080 cm -1 , respectively. An example of such a record plus the direct difference of two Raman images are shown in Figure 6 . It is obviously difficult to get useful information from the raw data before processing. The image processing algorithms developed based on the Raman imaging model were then used to explore the data step by step. Figures 7(g) and 7(h) illustrate the restored images using the EM-ML threedimensional deconvolution algorithm. The OTF of the Raman system, determined through measurement, was used here for the deconvolution.
Finally, the Raman image at 1080 cm -1 in Figure 7 (h) was subtracted from the Raman image at 1000 cm -1 in Figure 7 (g). The image after eliminating the fluorescence signal is shown in Figure 7 (i), which illustrates the paclitaxel distributions. The superimposition of the paclitaxel distribution image and the white light image in Figure   6 (a) is shown in Figure 7 (j), which illustrates the paclitaxel distribution in the cell.
RESULTS AND DISCUSSIONS
MD-435 tumor cells were exposed to the 0.3 mg/ml (or 350 µM) paclitaxel solution for one hour. The white light images and Raman images were obtained before, during, and after the Paclitaxel treatment ( Figure 8 ). All the Raman images were taken using a 60x water immersion lens with the exposure time of 300 seconds. They were processed using the method described above.
The first row in Figure 8 illustrates the images before drug treatment. These 
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The second and third rows in Figure 8 illustrate the images 10 minutes and 45 minutes into the drug treatment. These images suggest that the paclitaxel were accumulated outside the cell membrane and were gradually diffusing into the cell. The relative low Raman intensities in these two figures are probably because the cell is not in the PBS solution but in the drug solution, which contributes to a higher background than the PBS solution. After subtracting a higher average value from the image, its intensity became lower. In other words, the Raman intensities shown in the figures are relative after subtracting their average value. Therefore, the quantitative information was not preserved.
The fourth row through the seventh row in Figure 8 illustrate the images 10 minutes, 1.75 hours, 4 hours, and 4.5 hours after the drug treatment (after the paclitaxel agent was washed out). These images show that the Raman intensities are relatively higher in the center area as well as near the cell membrane. However, there is no intensity in the cell nucleus area. As we know, the Raman signal is directly related to the molecular concentration. The higher the intensity, the higher the molecular concentration. Therefore, these figures suggest that paclitaxel is more concentrated near the center of the cell as well as near the cell membrane, but less concentrated in the cell nucleus. The finding of paclitaxel distributions from the Raman images is explained by the binding characteristics of the paclitaxel and its molecular target -the microtubules.
Paclitaxel is an antimitotic drug, which stabilizes the microtubules, one type of cytoskeleton that plays an important role in cell division. Microtubules are long and hollow tubes of protein that grow out from a small structure near the center of the cell, called centrosome, and extend out towards the cell periphery (Figure 9(a) ). Microtubules can rapidly disassemble in one location and reassemble in another. When a cell enters mitosis (division), the microtubules disassemble and then reassemble into an intricate structure called the mitotic spindle (Figure 9(b) ). The mitotic spindle provides the machinery that will segregate the chromosomes equally into the two daughter cells just before a cell divides 44 . The action of paclitaxel is to bind tightly to the growth end of the microtubules (Figure 9(c) ). In this way, paclitaxel prevents the microtubules from losing subunits (i.e., depolymerization). Since new subunits can still be added (i.e., polymerization), the microtubules can grow but cannot shrink. In order for the spindle to work, the microtubules must be able not only to assemble but also to disassemble. Thus, paclitaxel prevents the mitotic spindle from functioning normally and the dividing cell is arrested in mitosis 44 .
The binding mechanism of paclitaxel suggests that the high paclitaxel concentration in the center area of the cell might be the location of the centrosome (further study is needed to prove this). The relatively high paclitaxel concentration near the cell membranes is probably because the growth ends of the microtubules extend to the membrane. These patterns of paclitaxel distribution were also observed in the studies of fluorescence imaging 4, 45 .
In Figure 8 , it was also found that the cell started blebbing around four hours after exposure to the paclitaxel solution, and the blebs progressively increased in size.
Previous studies [46] [47] [48] [49] [50] [51] [52] Although the concentration of the paclitaxel solution used in this study was much higher (ten to thirty-fold) than the regular clinical concentration, it may not indicate that we cannot visualize the drug at lower concentrations. In our study, the cells were exposed to the paclitaxel solution only for a short period. The drug was washed out after one hour. In the clinical situation, however, the cells are exposed to a lower concentration of drug for a longer time. The intensity of Raman image is related to the local molecular concentrations. If, after a period of time, the drug can be accumulated locally (at the microtubules' growth end), they can still be imaged even if the treatment drug concentration is low. Experiments will continue to perform on a low drug concentration to mimic the clinical situation.
In this study, the cells were found to be not tolerable to laser power more than 15 mW, even with a short imaging time. This may due to the slow heat dissipation around the cell (this experiment was performed in room temperature). If a temperature control incubator can be used during imaging to accelerate the heat dissipation, larger excitation power may be used to increase the Raman signal. Such a temperature incubator can also provide a constant temperature environment and gas environment for the living cells.
In this study, the white light images of the cells were taken by the video camera on the Raman system, which has relatively low resolutions. The CCD camera was not used to take the white light images due to the slow switch time between the white light imaging mode and Raman imaging mode of the system. In addition, re-calibration of the Raman tunable filter is often needed after switching back from the white light imaging mode. This re-calibration procedure is difficult to perform while monitoring the change of the drug distribution in a living cell. The future instrumentation should provide a different optical path to the CCD detector for the white light imaging. The improvement of the resolutions in white light cell images will make the drug location clearer.
CONCLUSIONS AND FUTURE DIRECTIONS
In this study, we presented and applied the direct Raman imaging techniques to Raman imaging is a promising tool to use for determining the intracellular distribution of a drug. Based on the drug distribution, Raman imaging can be further used to study the drug mechanism, cellular uptake, resistance, and intracellular pharmacokinetics. We believe that the direct Raman imaging will become a cost-effective tool for evaluating potential drugs at the cellular level.
In this study, only qualitative Raman information was preserved in the result images. The next step is to develop methods to quantify cellular drug uptake and retention under different drug concentrations. Quantification of the intercellular drug levels would be quite valuable for evaluating the intracellular pharmacokinetics of a drug.
Since the Raman signal intensity is linearly related to the concentration of the imaging molecules, we should be able to establish the relationship between intensity and concentration through a calibration procedure or by an internal standard.
We will continue to develop techniques to enhance the Raman signal. For example, the surface enhancement Raman (SERS) technique [53] [54] [55] [56] can be applied to direct imaging. It has shown that the Raman signals can be enhanced by factors of up to 10 6 when a molecule is adsorbed on or near a nanometer-size metal particle. We believe that 23 the current development of nanotechnology will make the SERS technique widely available.
We will also develop a Raman imaging system so that it can simultaneously take 
